Health Catalyst (NASDAQ:HCAT) Stock Price Down 2.9% – Here’s What Happened

Health Catalyst, Inc. (NASDAQ:HCAT) shares fell 2.9% during mid-day trading on Friday. The stock traded as low as $1.69 and last traded at $1.69. 159,996 shares traded hands during mid-day trading, a decline of 58% from the average session volume of 383,153 shares. The stock had previously closed at $1.74.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Weiss Ratings raised Health Catalyst from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, July 28th. Wells Fargo & Company dropped their target price on shares of Health Catalyst from $1.75 to $1.50 and set an “equal weight” rating on the stock in a report on Thursday, August 13th. Citigroup cut their price target on shares of Health Catalyst from $2.50 to $2.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 11th. Finally, Canaccord Genuity Group reiterated a “hold” rating and issued a $1.80 price target (down from $3.00) on shares of Health Catalyst in a report on Thursday, August 20th. Two analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $2.15.

Health Catalyst Stock Down 2.9%

The company has a debt-to-equity ratio of 1.51, a current ratio of 2.70 and a quick ratio of 2.70. The company has a market capitalization of $127.19 million, a price-to-earnings ratio of -0.46 and a beta of 1.54. The firm has a 50-day moving average price of $1.72 and a two-hundred day moving average price of $1.70.

Health Catalyst (NASDAQ:HCAT) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01. Health Catalyst had a negative return on equity of 1.83% and a negative net margin of 90.61%. The business had revenue of $70.49 million during the quarter, compared to the consensus estimate of $69.09 million. As a group, sell-side analysts anticipate that Health Catalyst, Inc. will post -0.18 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Health Catalyst news, CEO Simeon Kohl purchased 59,000 shares of the firm’s stock in a transaction dated Monday, September 14th. The stock was bought at an average cost of $1.79 per share, with a total value of $105,610.00. Following the purchase, the chief executive officer directly owned 2,856,385 shares of the company’s stock, valued at $5,112,929.15. The trade was a 2.11% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. 19.40% of the stock is currently owned by company insiders.

Institutional Trading of Health Catalyst

Institutional investors have recently made changes to their positions in the business. Squarepoint Ops LLC boosted its holdings in Health Catalyst by 1,214.8% during the second quarter. Squarepoint Ops LLC now owns 400,210 shares of the company’s stock worth $796,000 after purchasing an additional 369,772 shares during the last quarter. AXQ Capital LP bought a new position in Health Catalyst in the second quarter valued at $38,000. Headlands Technologies LLC bought a new position in Health Catalyst in the second quarter valued at $131,000. Hsbc Holdings PLC increased its stake in Health Catalyst by 313.3% in the 2nd quarter. Hsbc Holdings PLC now owns 408,634 shares of the company’s stock valued at $809,000 after buying an additional 309,766 shares during the last quarter. Finally, Palogic Value Management L.P. acquired a new stake in Health Catalyst in the 2nd quarter valued at $9,796,000. Institutional investors own 85.00% of the company’s stock.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services for healthcare organizations. Its solutions are designed to help hospitals, health systems and other providers organize clinical, operational and financial data, identify opportunities for improvement, and support more informed decisions.

The company’s offerings include its Health Catalyst Data Operating System, which integrates and manages healthcare data from multiple sources, along with analytics applications, artificial intelligence and machine-learning capabilities, and tools for population health, quality improvement, cost management and operational performance.